{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:35:18Z","timestamp":1792103718370,"version":"4.4.0"},"reference-count":331,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00073","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T03:47:14Z","timestamp":1497498434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":267,"title":["Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases"],"prefix":"10.3389","volume":"4","author":[{"given":"Christos P.","family":"Argyropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Harn","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Eleni","family":"Roumelioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Shaffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios H.","family":"Tzamaloukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"B1","volume-title":"USRDS 2015 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.106.177321","article-title":"Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation","volume":"48","author":"Brosius","year":"2006","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinternmed.2011.2230","article-title":"Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes","volume":"172","author":"Coca","year":"2012","journal-title":"Arch Intern Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1525-139x.2001.00037.x","article-title":"Pathological aspects of beta(2)-microglobulin amyloidosis","volume":"14","author":"Jadoul","year":"2001","journal-title":"Semin Dial"},{"key":"B10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/sdi.12590","article-title":"Dialysis-related amyloidosis: is it gone or should it be?","volume":"30","author":"Labriola","year":"2017","journal-title":"Semin Dial"},{"key":"B11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2147\/IJNRD.S84784","article-title":"Dialysis-related amyloidosis: challenges and solutions","volume":"9","author":"Scarpioni","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B12","first-page":"31","article-title":"Amyloidosis and its impact on patients with ESRD","volume":"33","author":"Copeland","year":"2006","journal-title":"Nephrol Nurs J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1525-139x.2001.00035.x","article-title":"Dialysis-related amyloidosis: history and clinical manifestations","volume":"14","author":"Danesh","year":"2001","journal-title":"Semin Dial"},{"key":"B14","first-page":"718","article-title":"Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature","volume":"118","author":"Gal","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/ki.1997.262","article-title":"Histological prevalence of \u03b22-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study","volume":"51","author":"Jadoul","year":"1997","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1046\/j.1523-1755.1998.00064.x","article-title":"Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients","volume":"54","author":"Jadoul","year":"1998","journal-title":"Kidney Int"},{"key":"B17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1172\/JCI117002","article-title":"Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1","volume":"93","author":"Miyata","year":"1994","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbapap.2005.09.006","article-title":"Historical background and clinical treatment of dialysis-related amyloidosis","volume":"1753","author":"Yamamoto","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1525-139x.2001.00038.x","article-title":"Dialysis-related amyloidosis after renal transplantation","volume":"14","author":"Campistol","year":"2001","journal-title":"Semin Dial"},{"key":"B20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.0954-6820.1985.tb08880.x","article-title":"Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate","volume":"218","author":"Grubb","year":"1985","journal-title":"Acta Med Scand"},{"key":"B21","first-page":"S20","article-title":"Diagnostic value of analysis of cystatin C and protein HC in biological fluids","volume":"38","author":"Grubb","year":"1992","journal-title":"Clin Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/00365519709084595","article-title":"Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin\/cystatin C-ratio","volume":"57","author":"Norlund","year":"1997","journal-title":"Scand J Clin Lab Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/978-94-007-5416-4_19","article-title":"\u03b2(2)-microglobulin amyloidosis","volume":"65","author":"Corlin","year":"2012","journal-title":"Subcell Biochem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/13506120903151775","article-title":"\u03b22-microglobulin: from physiology to amyloidosis","volume":"16","author":"Heegaard","year":"2009","journal-title":"Amyloid"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9951","DOI":"10.1074\/jbc.R115.639799","article-title":"Systemic amyloidosis: lessons from \u03b22-microglobulin","volume":"290","author":"Stoppini","year":"2015","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1111\/j.1742-4658.2011.08186.x","article-title":"Understanding the complex mechanisms of \u03b22-microglobulin amyloid assembly","volume":"278","author":"Eichner","year":"2011","journal-title":"FEBS J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1053\/j.arrt.2003.11.003","article-title":"Beta-2 microglobulin in ESRD: an in-depth review","volume":"10","author":"Winchester","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"B28","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1016\/S0021-9258(18)93284-9","article-title":"Isolation and properties of a low molecular weight \u03b22-globulin occurring in human biological fluids","volume":"243","author":"Bergg\u00e5rd","year":"1968","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1073\/pnas.82.12.4225","article-title":"Three-dimensional structure of beta 2-microglobulin","volume":"82","author":"Becker","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jb\/mvm148","article-title":"High-resolution crystal structure of beta2-microglobulin formed at pH 7.0","volume":"142","author":"Iwata","year":"2007","journal-title":"J Biochem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.2137259","article-title":"Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum","volume":"247","author":"Cox","year":"1990","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/346751a0","article-title":"Beta 2-microglobulin restriction of antigen presentation","volume":"346","author":"Perarnau","year":"1990","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1006\/bbrc.2001.6277","article-title":"Association of MR1 protein, an MHC class I-related molecule, with \u03b22-microglobulin","volume":"290","author":"Yamaguchi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.humimm.2006.09.003","article-title":"Structural studies on HLA-G: implications for ligand and receptor binding","volume":"68","author":"Clements","year":"2007","journal-title":"Hum Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.4049\/jimmunol.175.8.4866","article-title":"The CD85J\/leukocyte inhibitory receptor-1 distinguishes between conformed and {beta}2-microglobulin-free HLA-G molecules","volume":"175","author":"Gonen-Gross","year":"2005","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.4049\/jimmunol.1403014","article-title":"FcRn: the architect behind the immune and nonimmune functions of IgG and albumin","volume":"194","author":"Pyzik","year":"2015","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/0971-6866.142855","article-title":"Mammalian non-classical major histocompatibility complex I and its receptors: important contexts of gene, evolution, and immunity","volume":"20","author":"Pratheek","year":"2014","journal-title":"Indian J Hum Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/18715206113139990092","article-title":"\u03b22-Microglobulin-mediated signaling as a target for cancer therapy","volume":"14","author":"Nomura","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/imr.12331","article-title":"The multiple facets of FcRn in immunity","volume":"268","author":"Stapleton","year":"2015","journal-title":"Immunol Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2016.03.007","article-title":"A comprehensive review of the neonatal Fc receptor and its application in drug delivery","volume":"161","author":"Martins","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/337184a0","article-title":"An Fc receptor structurally related to MHC class I antigens","volume":"337","author":"Simister","year":"1989","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.4049\/jimmunol.154.12.6246","article-title":"Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice","volume":"154","author":"Israel","year":"1995","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1073\/pnas.93.11.5512","article-title":"The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor","volume":"93","author":"Junghans","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1242\/jcs.108.6.2347","article-title":"Beta 2-microglobulin co-distributes with the heavy chain of the intestinal IgG-Fc receptor throughout the transepithelial transport pathway of the neonatal rat","volume":"108","author":"Berryman","year":"1995","journal-title":"J Cell Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/eji.1830260327","article-title":"Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice","volume":"26","author":"Ghetie","year":"1996","journal-title":"Eur J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1042\/bj20020200","article-title":"The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of \u03b22-microglobulin association","volume":"367","author":"Zhu","year":"2002","journal-title":"Biochem J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.clim.2006.09.001","article-title":"Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model","volume":"122","author":"Kim","year":"2007","journal-title":"Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B51","doi-asserted-by":"publisher","first-page":"F941","DOI":"10.1152\/ajprenal.00532.2013","article-title":"Human podocytes perform polarized, caveolae-dependent albumin endocytosis","volume":"306","author":"Dobrinskikh","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1681\/ASN.2013010018","article-title":"Albumin is recycled from the primary urine by tubular transcytosis","volume":"24","author":"Tenten","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1681\/ASN.2008090976","article-title":"Renal FcRn reclaims albumin but facilitates elimination of IgG","volume":"20","author":"Sarav","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.humpath.2011.10.025","article-title":"Neonatal Fc receptor stimulation induces ubiquitin c-terminal hydrolase-1 overexpression in podocytes through activation of p38 mitogen-activated protein kinase","volume":"43","author":"Gan","year":"2012","journal-title":"Hum Pathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1097\/01.ASN.0000099702.16315.DE","article-title":"Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen \u03b15(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes","volume":"14","author":"Kang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1681\/ASN.2004121084","article-title":"Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome","volume":"16","author":"Koshikawa","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/HYPERTENSIONAHA.111.00639","article-title":"Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agentsnovelty and significance","volume":"61","author":"Kavvadas","year":"2013","journal-title":"Hypertension"},{"key":"B58","doi-asserted-by":"publisher","first-page":"46624","DOI":"10.1038\/srep46624","article-title":"Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition","volume":"7","author":"Kato","year":"2017","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How does proteinuria cause progressive renal damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1681\/ASN.2012040390","article-title":"Mechanisms and treatment of CKD","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e54817","DOI":"10.1371\/journal.pone.0054817","article-title":"Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death","volume":"8","author":"Okamura","year":"2013","journal-title":"PLoS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1681\/ASN.2012111112","article-title":"NADPH oxidases, reactive oxygen species, and the kidney: friend and foe","volume":"24","author":"Sedeek","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e7813072","DOI":"10.1155\/2016\/7813072","article-title":"Role of NADPH oxidase in metabolic disease-related renal injury: an update","volume":"2016","author":"Wan","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fphys.2017.00074","article-title":"Stress signal network between hypoxia and ER stress in chronic kidney disease","volume":"8","author":"Maekawa","year":"2017","journal-title":"Front Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1440-1797.2012.01572.x","article-title":"Oxidative stress, anti-oxidant therapies and chronic kidney disease","volume":"17","author":"Small","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"CD008176","DOI":"10.1002\/14651858.CD008176.pub2","article-title":"Antioxidants for chronic kidney disease","volume":"10","author":"Jun","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/HJH.0b013e32834786f0","article-title":"Albumin overload activates intrarenal renin-angiotensin system through protein kinase C and NADPH oxidase-dependent pathway","volume":"29","author":"Cao","year":"2011","journal-title":"J Hypertens"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/ki.2011.282","article-title":"Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase","volume":"80","author":"Kinugasa","year":"2011","journal-title":"Kidney Int"},{"key":"B70","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000448789","article-title":"Aliskiren regulates neonatal Fc receptor and IgG metabolism with attenuation of anti-GBM glomerulonephritis in mice","volume":"134","author":"Kang","year":"2016","journal-title":"Nephron"},{"key":"B71","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1681\/ASN.2013050498","article-title":"Neonatal Fc receptor promotes immune complex\u2013mediated glomerular disease","volume":"25","author":"Olaru","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/art.39499","article-title":"Lupus nephritis IgG induction of calcium\/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function","volume":"68","author":"Ichinose","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1681\/ASN.2010050492","article-title":"Cubilin is essential for albumin reabsorption in the renal proximal tubule","volume":"21","author":"Amsellem","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jconrel.2015.06.006","article-title":"The role of albumin receptors in regulation of albumin homeostasis: implications for drug delivery","volume":"211","author":"Bern","year":"2015","journal-title":"J Control Release"},{"key":"B75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1681\/ASN.2013090950","article-title":"The proximal tubule and albuminuria: really!","volume":"25","author":"Dickson","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1056\/NEJM196911202812107","article-title":"Disorders of immunoglobulin metabolism","volume":"281","author":"Waldmann","year":"1969","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1172\/JCI114947","article-title":"Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin","volume":"86","author":"Waldmann","year":"1990","journal-title":"J Clin Invest"},{"key":"B78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jaci.2014.12.1937","article-title":"\u03b22-microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system","volume":"136","author":"Ardeniz","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1073\/pnas.0600548103","article-title":"Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene","volume":"103","author":"Wani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0165-2478(94)90094-9","article-title":"Iron overload in beta 2-microglobulin-deficient mice","volume":"39","author":"de Sousa","year":"1994","journal-title":"Immunol Lett"},{"key":"B81","doi-asserted-by":"publisher","first-page":".e1","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment","volume":"139","author":"Pietrangelo","year":"2010","journal-title":"Gastroenterology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2010.08.031","article-title":"Natural killer cell education and tolerance","volume":"142","author":"Orr","year":"2010","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1084\/jem.184.5.1975","article-title":"Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man","volume":"184","author":"Santos","year":"1996","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1073\/pnas.89.13.6070","article-title":"Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses","volume":"89","author":"Spriggs","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B85","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3181\/0710-RM-270","article-title":"Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice","volume":"233","author":"Kim","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1084\/jem.20020897","article-title":"Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis","volume":"196","author":"Schaible","year":"2002","journal-title":"J Exp Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2613.2006.00491.x","article-title":"Comparative study between Hfe-\/- and beta2m-\/- mice: progression with age of iron status and liver pathology","volume":"87","author":"Rodrigues","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bcmd.2004.05.003","article-title":"Molecular analysis of iron overload in beta2-microglobulin-deficient mice","volume":"33","author":"Muckenthaler","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2003-09-3300","article-title":"Contributions of \u03b22-microglobulin\u2013dependent molecules and lymphocytes to iron regulation: insights from HfeRag1-\/- and \u03b22mRag1-\/- double knock-out mice","volume":"103","author":"Miranda","year":"2004","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S0002-9440(10)64305-2","article-title":"beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis","volume":"162","author":"Klingel","year":"2003","journal-title":"Am J Pathol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1164\/rccm.200208-950OC","article-title":"{beta}2 microglobulin knockout mice are resistant to lethal intraabdominal sepsis","volume":"167","author":"Sherwood","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/cimm.1996.0276","article-title":"Altered kinetics of CD4+ T cell proliferation and interferon-gamma production in the absence of CD8+ T lymphocytes in virus-infected beta2-microglobulin-deficient mice","volume":"173","author":"Vikingsson","year":"1996","journal-title":"Cell Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/356338a0","article-title":"Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection","volume":"356","author":"Tarleton","year":"1992","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1165\/ajrcmb.23.2.4063","article-title":"A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung","volume":"23","author":"D\u2019Souza","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0264-410X(96)00028-X","article-title":"Vaccination protects beta 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection","volume":"14","author":"Hildeman","year":"1996","journal-title":"Vaccine"},{"key":"B97","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1128\/IAI.00909-08","article-title":"Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia","volume":"77","author":"Cogen","year":"2009","journal-title":"Infect Immun"},{"key":"B98","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.153.7.3116","article-title":"Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection","volume":"153","author":"Ladel","year":"1994","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"14668","DOI":"10.1128\/JVI.79.23.14668-14679.2005","article-title":"Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice","volume":"79","author":"Tarakanova","year":"2005","journal-title":"J Virol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/viro.1998.9455","article-title":"Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis","volume":"252","author":"Drake","year":"1998","journal-title":"Virology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.8316860","article-title":"Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus","volume":"261","author":"Mozes","year":"1993","journal-title":"Science"},{"key":"B102","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4049\/jimmunol.154.5.2063","article-title":"Decreased CD4-CD8- TCR-alpha beta + cells in lpr\/lpr mice lacking beta 2-microglobulin","volume":"154","author":"Mixter","year":"1995","journal-title":"J Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.4049\/jimmunol.167.5.2985","article-title":"Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(lpr) nice: an example of disease regulation at the organ level","volume":"167","author":"Chan","year":"2001","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.4049\/jimmunol.156.12.4932","article-title":"beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice","volume":"156","author":"Christianson","year":"1996","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4049\/jimmunol.1203217","article-title":"IFN-\u03b3\u2013producing effector CD8 T lymphocytes cause immune glomerular injury by recognizing antigen presented as immune complex on target tissue","volume":"191","author":"Tsumiyama","year":"2013","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.gene.2015.10.009","article-title":"HFE gene: structure, function, mutations, and associated iron abnormalities","volume":"574","author":"Barton","year":"2015","journal-title":"Gene"},{"key":"B107","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbrc.2008.11.118","article-title":"Knockdown of beta2-microglobulin perturbs the subcellular distribution of HFE and hepcidin","volume":"378","author":"Bhatt","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B108","first-page":"447","article-title":"Beta-2 microglobulin \u2013 an immunogenetic marker of inflammatory and malignant origin","volume":"12","author":"Forman","year":"1982","journal-title":"Ann Clin Lab Sci"},{"key":"B109","unstructured":"FB2MU \u2013 Overview: Beta-2-Microglobulin, Urine2017"},{"key":"B110","unstructured":"B2M \u2013 Overview: Beta-2-Microglobulin (Beta-2-M), Serum2017"},{"key":"B111","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01546321","article-title":"Factors influencing serum neopterin and beta 2-microglobulin levels in a healthy diverse population","volume":"14","author":"Diamondstone","year":"1994","journal-title":"J Clin Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2215\/CJN.08700812","article-title":"Comparison of serum concentrations of \u03b2-trace protein, \u03b22-microglobulin, cystatin C, and creatinine in the US population","volume":"8","author":"Juraschek","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B113","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/clinchem\/28.10.2033","article-title":"Beta 2-microglobulin determined by radioimmunoassay with monoclonal antibody","volume":"28","author":"Swanson","year":"1982","journal-title":"Clin Chem"},{"key":"B114","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2249.1991.tb05802.x","article-title":"Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma)","volume":"86","author":"Aulitzky","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0171-2985(88)80092-5","article-title":"Cytokines in the control of beta-2 microglobulin release. I. In vitro studies on various haemopoietic cells","volume":"177","author":"Nachbaur","year":"1988","journal-title":"Immunobiology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0171-2985(88)80092-5","article-title":"Cytokines in the control of beta-2 microglobulin release. II. In vivo studies with recombinant interferons and antigens","volume":"177","author":"Nachbaur","year":"1988","journal-title":"Immunobiology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0153157","DOI":"10.1371\/journal.pone.0153157","article-title":"Revisiting the middle molecule hypothesis of uremic toxicity: a systematic review of beta 2 microglobulin population kinetics and large scale modeling of hemodialysis trials in silico","volume":"11","author":"Roumelioti","year":"2016","journal-title":"PLoS One"},{"key":"B118","unstructured":"GooptuM StarosE Beta2-Microglobulin: Reference Range, Interpretation, Collection and Panels2016"},{"key":"B119","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.ajkd.2015.06.020","article-title":"Kidney function and fracture risk: the atherosclerosis risk in communities (ARIC) study","volume":"67","author":"Daya","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/22953337.1980.11718773","article-title":"Plasma beta 2 microglobulin turnover in renal insufficiency","volume":"35","author":"Vincent","year":"1980","journal-title":"Acta Clin Belg Suppl"},{"key":"B121","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000180203","article-title":"Serum 2 -microglobulin in renal disease","volume":"10","author":"Wibell","year":"1973","journal-title":"Nephron"},{"key":"B122","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000182234","article-title":"Prediction of glomerular filtration rate by serum creatinine and beta 2-microglobulin","volume":"29","author":"Shea","year":"1981","journal-title":"Nephron"},{"key":"B123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/j.ajkd.2015.07.025","article-title":"GFR estimation using \u03b2-trace protein and \u03b22-microglobulin in CKD","volume":"67","author":"Inker","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/jcp.43.5.370","article-title":"Measurement of glomerular filtration rate in homozygous sickle cell disease: a comparison of 51Cr-EDTA clearance, creatinine clearance, serum creatinine and beta 2 microglobulin","volume":"43","author":"Aparicio","year":"1990","journal-title":"J Clin Pathol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3346\/jkms.2006.21.4.639","article-title":"Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myeloma","volume":"21","author":"Yun","year":"2006","journal-title":"J Korean Med Sci"},{"key":"B126","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1081\/JDI-120017475","article-title":"Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate","volume":"25","author":"Jovanovi\u0107","year":"2003","journal-title":"Ren Fail"},{"key":"B127","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-2004-817933","article-title":"Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy","volume":"112","author":"Aksun","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B128","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1081\/JDI-100104725","article-title":"Reappraisal of serum beta2-microglobulin as marker of GFR","volume":"23","author":"Bianchi","year":"2001","journal-title":"Ren Fail"},{"key":"B129","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0731-7085(00)00550-1","article-title":"Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine","volume":"24","author":"Donadio","year":"2001","journal-title":"J Pharm Biomed Anal"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0731-7085(03)00215-2","article-title":"Serum levels of beta-trace protein and glomerular filtration rate \u2013 preliminary results","volume":"32","author":"Donadio","year":"2003","journal-title":"J Pharm Biomed Anal"},{"key":"B131","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000104870","article-title":"Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration","volume":"25","author":"Fry","year":"2007","journal-title":"Blood Purif"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e0143813","DOI":"10.1371\/journal.pone.0143813","article-title":"Plasma levels of middle molecules to estimate residual kidney function in haemodialysis without urine collection","volume":"10","author":"Vilar","year":"2015","journal-title":"PLoS One"},{"key":"B133","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1053\/j.ajkd.2016.07.021","article-title":"Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD","volume":"68","author":"Liu","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B134","first-page":"926","article-title":"Biomarkers in acute and chronic kidney diseases","volume-title":"Brenner and Rector\u2019s The Kidney","author":"Parikh","year":"2015"},{"key":"B135","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinchem\/43.6.1077","article-title":"Are cystatin C and \u03b22-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects?","volume":"43","author":"Filler","year":"1997","journal-title":"Clin Chem"},{"key":"B136","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10157-012-0658-7","article-title":"Establishment of a normal reference value for serum \u03b22 microglobulin in Japanese children: reevaluation of its clinical usefulness","volume":"17","author":"Ikezumi","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s10157-014-1015-9","article-title":"Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents","volume":"19","author":"Ikezumi","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"B138","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/clinchem\/48.5.729","article-title":"Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children","volume":"48","author":"Filler","year":"2002","journal-title":"Clin Chem"},{"key":"B139","first-page":"59","article-title":"Estimation of glomerular filtration rate from beta 2-microglobulin serum levels in children","volume":"5","author":"Van Acker","year":"1984","journal-title":"Int J Pediatr Nephrol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s00467-016-3493-3","article-title":"Can the new CKD-EPI BTP-B2M formula be applied in children?","volume":"31","author":"Filler","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1172\/JCI106083","article-title":"Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of \u03b22-microglobulin, albumin, and total protein","volume":"48","author":"Peterson","year":"1969","journal-title":"J Clin Invest"},{"key":"B142","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/ki.1986.156","article-title":"Use of beta 2 microglobulin to diagnose tubulo-interstitial renal lesions in children","volume":"30","author":"Portman","year":"1986","journal-title":"Kidney Int"},{"key":"B143","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1152\/physiol.00022.2012","article-title":"Endocytic receptors in the renal proximal tubule","volume":"27","author":"Christensen","year":"2012","journal-title":"Physiology (Bethesda)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int"},{"key":"B145","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1681\/ASN.V9101759","article-title":"Megalin is an endocytic receptor for insulin","volume":"9","author":"Orlando","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0002-9440(10)65238-8","article-title":"Megalin knockout mice as an animal model of low molecular weight proteinuria","volume":"155","author":"Leheste","year":"1999","journal-title":"Am J Pathol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/ndt\/gfs462","article-title":"Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration","volume":"28","author":"Storm","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B148","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/ng2063","article-title":"Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes","volume":"39","author":"Kantarci","year":"2007","journal-title":"Nat Genet"},{"key":"B149","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMc1009804","article-title":"A patient with cubilin deficiency","volume":"364","author":"Storm","year":"2011","journal-title":"N Engl J Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nrm778","article-title":"Megalin and cubilin: multifunctional endocytic receptors","volume":"3","author":"Christensen","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B151","first-page":"F380","article-title":"Characterization of the beta 2-microglobulin endocytic pathway in rat proximal tubule cells","volume":"267","author":"Sundin","year":"1994","journal-title":"Am J Physiol"},{"key":"B152","first-page":"F829","article-title":"Convergence of apical and basolateral endocytic pathways for beta 2-microglobulin in LLC-PK1 cells","volume":"268","author":"Cohen","year":"1995","journal-title":"Am J Physiol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"F358","DOI":"10.1152\/ajprenal.0164.2001","article-title":"FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells","volume":"282","author":"Kobayashi","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ki.1984.151","article-title":"Renal tubular absorption of beta 2 microglobulin","volume":"26","author":"Gauthier","year":"1984","journal-title":"Kidney Int"},{"key":"B155","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ki.1988.163","article-title":"The renal uptake of proteins: a nonselective process in conscious rats","volume":"34","author":"Bernard","year":"1988","journal-title":"Kidney Int"},{"key":"B156","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000187863","article-title":"Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies","volume":"66","author":"Thielemans","year":"1994","journal-title":"Nephron"},{"key":"B157","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000184090","article-title":"Competition between low- and high-molecular-weight proteins for renal tubular uptake","volume":"45","author":"Bernard","year":"1987","journal-title":"Nephron"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1046\/j.1523-1755.1998.00098.x","article-title":"Measurement of the kinetics of protein uptake by proximal tubular cells using an optical biosensor","volume":"54","author":"Thakkar","year":"1998","journal-title":"Kidney Int"},{"key":"B159","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1651-2227.1979.tb18435.x","article-title":"A prospective study of urinary proteins in early infancy","volume":"68","author":"Karlsson","year":"1979","journal-title":"Acta Paediatr Scand"},{"key":"B160","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nbt.1622","article-title":"Urinary clusterin, cystatin C, \u03b22-microglobulin and total protein as markers to detect drug-induced kidney injury","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1293\/tox.2014-0039","article-title":"Comparison of changes in urinary and blood levels of biomarkers associated with proximal tubular injury in rat models","volume":"28","author":"Kuwata","year":"2015","journal-title":"J Toxicol Pathol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/toxsci\/kft330","article-title":"Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies","volume":"138","author":"Vlasakova","year":"2014","journal-title":"Toxicol Sci"},{"key":"B163","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3904\/kjim.2014.29.3.334","article-title":"Urinary excretion of \u03b22-microglobulin as a prognostic marker in immunoglobulin A nephropathy","volume":"29","author":"Shin","year":"2014","journal-title":"Korean J Intern Med"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1177\/0961203314547797","article-title":"Urine \u03b22-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus","volume":"23","author":"Choe","year":"2014","journal-title":"Lupus"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00134-007-0656-5","article-title":"Urinary biomarkers in septic acute kidney injury","volume":"33","author":"Bagshaw","year":"2007","journal-title":"Intensive Care Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e492838","DOI":"10.1155\/2014\/492838","article-title":"Urinary beta2-microglobulin is a good indicator of proximal tubule injury: a correlative study with renal biopsies","volume":"2014","author":"Zeng","year":"2014","journal-title":"J Biomarkers"},{"key":"B167","first-page":"530","article-title":"The significance of beta-2 microglobulinuria associated with gentamicin therapy","volume":"11","author":"Kaye","year":"1981","journal-title":"Ann Clin Lab Sci"},{"key":"B168","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0009-8981(91)90133-W","article-title":"Stability of beta 2-microglobulin and retinol binding protein at different values of pH and temperature in normal and pathological urine","volume":"195","author":"Blumsohn","year":"1991","journal-title":"Clin Chim Acta"},{"key":"B169","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0009-8981(89)90024-7","article-title":"Stability of alpha 1-microglobulin, beta 2-microglobulin and retinol binding protein in urine","volume":"179","author":"Donaldson","year":"1989","journal-title":"Clin Chim Acta"},{"key":"B170","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/clinchem\/29.5.996","article-title":"Beta 2 microglobulin in urine: not suitable for assessing renal tubular function","volume":"29","author":"Bastable","year":"1983","journal-title":"Clin Chem"},{"key":"B171","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/clinchem\/33.6.775","article-title":"Assessment of urinary retinol-binding protein as an index of proximal tubular injury","volume":"33","author":"Bernard","year":"1987","journal-title":"Clin Chem"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e115794","DOI":"10.1371\/journal.pone.0115794","article-title":"Benchmark dose estimation for cadmium-induced renal tubular damage among environmental cadmium-exposed women aged 35\u201354 years in two counties of China","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"B173","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12889-015-2021-x","article-title":"Estimation of the benchmark dose of urinary cadmium as the reference level for renal dysfunction: a large sample study in five cadmium polluted areas in China","volume":"15","author":"Ke","year":"2015","journal-title":"BMC Public Health"},{"key":"B174","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.etap.2014.10.016","article-title":"Temporal changes in urinary levels of cadmium, N-acetyl-\u03b2-d-glucosaminidase and \u03b22-microglobulin in individuals in a cadmium-contaminated area","volume":"39","author":"Kim","year":"2015","journal-title":"Environ Toxicol Pharmacol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/1471-2458-14-702","article-title":"Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand","volume":"14","author":"Nishijo","year":"2014","journal-title":"BMC Public Health"},{"key":"B176","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/hup.2362","article-title":"Novel markers of kidney injury in bipolar patients on long-term lithium treatment","volume":"28","author":"Rybakowski","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"e29977","DOI":"10.1371\/journal.pone.0029977","article-title":"Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naive patients with HIV infection","volume":"7","author":"Nishijima","year":"2012","journal-title":"PLoS One"},{"key":"B178","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/QAI.0b013e31828175c9","article-title":"Tenofovir use and urinary biomarkers among HIV-infected women in the Women\u2019s Interagency HIV Study (WIHS)","volume":"62","author":"Oboho","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B179","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1089\/aid.2006.22.744","article-title":"Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate","volume":"22","author":"Gatanaga","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B180","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00467-016-3394-5","article-title":"Tubulointerstitial nephritis: diagnosis, treatment, and monitoring","volume":"32","author":"Joyce","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004670050278","article-title":"Low molecular weight protein excretion in glomerular disease: a comparative analysis","volume":"11","author":"Tomlinson","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/jamaophthalmol.2014.4301","article-title":"The value of measuring urinary \u03b22-microglobulin and serum creatinine for detecting tubulointerstitial nephritis and uveitis syndrome in young patients with uveitis","volume":"133","author":"Hettinga","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/nep.12040","article-title":"Renal tubular dysfunction in children with sickle cell haemoglobinopathy","volume":"18","author":"Badr","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"B184","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/08880018.2013.810317","article-title":"Beta2 microglobulin, N-acetyl-beta-d-glucosaminidase, retinol-binding protein, and endothelin 1 levels in the evaluation of sickle cell disease nephropathy","volume":"32","author":"Unal","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/MPH.0b013e318257fd89","article-title":"Renal function and low-molecular-weight proteins (cystatin C, \u03b22-microglobulin, neutrophil gelatinase-associated lipocalin) in child and young adult cancer survivors","volume":"34","author":"Stefanowicz","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22088","article-title":"Detection of PCT and urinary \u03b22 -MG enhances the accuracy for localization diagnosing pediatric urinary tract infection","author":"Fang","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"B187","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1203\/00006450-198911000-00035","article-title":"Urinary excretion of beta-2-microglobulin in children with urinary tract infections","volume":"26","author":"Korpal-Szczyrska","year":"1989","journal-title":"Pediatr Res"},{"key":"B188","first-page":"83","article-title":"[Beta 2 microglobulin in the diagnosis of reflux nephropathy in childhood]","volume":"10","author":"Salvaggio","year":"1988","journal-title":"Pediatr Med Chir"},{"key":"B189","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00467-012-2217-6","article-title":"Urinary NGAL, cystatin C, \u03b22-microglobulin, and osteopontin significance in hydronephrotic children","volume":"27","author":"Madsen","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4103\/1319-2442.160151","article-title":"Serum cystatin-C and BETA 2-microglobulin as accurate markers in the early diagnosis of kidney injury in neonates: a single center study","volume":"26","author":"El-Frargy","year":"2015","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B191","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/cc5923","article-title":"Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children","volume":"11","author":"Herrero-Mor\u00edn","year":"2007","journal-title":"Crit Care"},{"key":"B192","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00467-010-1673-0","article-title":"Urinary biomarkers to detect acute kidney injury in the pediatric emergency center","volume":"26","author":"Du","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1203\/PDR.0b013e3182275164","article-title":"Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants","volume":"70","author":"Askenazi","year":"2011","journal-title":"Pediatr Res"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00467-016-3327-3","article-title":"Longitudinal patterns of urine biomarkers in infants across gestational ages","volume":"31","author":"DeFreitas","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ki.2012.301","article-title":"Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients","volume":"82","author":"Liabeuf","year":"2012","journal-title":"Kidney Int"},{"key":"B196","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.ajkd.2016.01.015","article-title":"Serum \u03b2-trace protein and \u03b22-microglobulin as predictors of ESRD, mortality, and cardiovascular disease in adults with CKD in the chronic renal insufficiency cohort (CRIC) study","volume":"68","author":"Foster","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B197","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.ajkd.2015.01.013","article-title":"Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes","volume":"66","author":"Foster","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B198","doi-asserted-by":"publisher","first-page":"e22056","DOI":"10.1002\/jcla.22056","article-title":"Associations among serum beta 2 microglobulin, malnutrition, inflammation, and advanced cardiovascular event in patients with chronic kidney disease","volume":"31","author":"Wu","year":"2017","journal-title":"J Clin Lab Anal"},{"key":"B199","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2215\/CJN.03660316","article-title":"Filtration markers as predictors of ESRD and mortality: individual participant data meta-analysis","volume":"12","author":"Inker","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2011.11.042","article-title":"Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population","volume":"59","author":"Astor","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B201","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ahj.2016.07.004","article-title":"Kidney function and sudden cardiac death in the community: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"180","author":"Suzuki","year":"2016","journal-title":"Am Heart J"},{"key":"B202","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2013.01.016","article-title":"Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults","volume":"62","author":"Foster","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.kint.2015.12.042","article-title":"Predicting residual kidney function in hemodialysis patients using serum \u03b2-trace protein and \u03b22-microglobulin","volume":"89","author":"Wong","year":"2016","journal-title":"Kidney Int"},{"key":"B204","first-page":"349","article-title":"Evidence for toxins of \u201cmiddle\u201d molecular weight","volume":"3","author":"Scribner","year":"1975","journal-title":"Kidney Int Suppl"},{"key":"B205","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0272-6386(81)80011-X","article-title":"The middle molecule hypothesis in perspective","volume":"1","author":"Babb","year":"1981","journal-title":"Am J Kidney Dis"},{"key":"B206","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1093\/ndt\/gfs475","article-title":"Clearance of middle molecules during haemodialysis and haemodiafiltration: new insights","volume":"27","author":"Leypoldt","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B207","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1525-139X.2009.00665.x","article-title":"Innovation in the treatment of uremia: proceedings from the Cleveland clinic workshop: convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence","volume":"22","author":"Thomas","year":"2009","journal-title":"Semin Dial"},{"key":"B208","doi-asserted-by":"publisher","first-page":"ii205","DOI":"10.1093\/ndt\/gfs224","article-title":"Comparison of on-line HDF modes automated TMP control vs. volume control on achieved convective volume and middle molecule clearance","volume":"27","author":"Panichi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B209","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000107251","article-title":"Clearance of beta-2-microglobulin and middle molecules in haemodiafiltration","volume":"158","author":"Tattersall","year":"2007","journal-title":"Contrib Nephrol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/ndt\/gfn521","article-title":"Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients","volume":"24","author":"Okuno","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B211","doi-asserted-by":"publisher","first-page":"458","DOI":"10.5414\/CNP75458","article-title":"Higher serum beta2-microglobulin levels are associated with better survival in chronic hemodialysis patients: a reverse epidemiology","volume":"75","author":"Kim","year":"2011","journal-title":"Clin Nephrol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1093\/ndt\/12.11.2365","article-title":"Dissociation between beta-2 microglobulin and IL-1 production in hemodialyzed patients","volume":"12","author":"Carreno","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"B213","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1177\/039139889001301205","article-title":"Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients","volume":"13","author":"Caruana","year":"1990","journal-title":"Int J Artif Organs"},{"key":"B214","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ki.1992.292","article-title":"Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells","volume":"42","author":"Memoli","year":"1992","journal-title":"Kidney Int"},{"key":"B215","first-page":"18","article-title":"Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin","volume":"6","author":"Pertosa","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"B216","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000368940","article-title":"Update on inflammation in chronic kidney disease","volume":"39","author":"Akchurin","year":"2015","journal-title":"Blood Purif"},{"key":"B217","doi-asserted-by":"publisher","first-page":"348","DOI":"10.5455\/medarh.2016.70.348-350","article-title":"Association of beta-2 microglobulin with inflammation and dislipidemia in high-flux membrane hemodialysis patients","volume":"70","author":"Top\u00e7iu-Shufta","year":"2016","journal-title":"Med Arch"},{"key":"B218","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000070694","article-title":"A switch to high-flux helixone membranes reverses suppressed interferon-gamma production in patients on low-flux dialysis","volume":"21","author":"Lonnemann","year":"2003","journal-title":"Blood Purif"},{"key":"B219","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5414\/CNP72170","article-title":"Low-flux hemodialysis suppresses interferon-gamma production: the possible role of beta2-microglobulin","volume":"72","author":"Lonnemann","year":"2009","journal-title":"Clin Nephrol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"CD005016","DOI":"10.1002\/14651858.CD005016.pub2","article-title":"High-flux versus low-flux membranes for end-stage kidney disease","volume":"9","author":"Palmer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B221","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med"},{"key":"B222","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1097\/01.ASN.0000096373.13406.94","article-title":"Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study","volume":"14","author":"Cheung","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.ajkd.2005.09.031","article-title":"Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study","volume":"47","author":"Delmez","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B224","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1681\/ASN.2005020132","article-title":"Serum \u03b2-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study","volume":"17","author":"Cheung","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2215\/CJN.02340607","article-title":"Association between serum \u03b22-microglobulin level and infectious mortality in hemodialysis patients","volume":"3","author":"Cheung","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000110574","article-title":"The MPO Study: just a European HEMO Study or something very different?","volume":"26","author":"Locatelli","year":"2008","journal-title":"Blood Purif"},{"key":"B227","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1681\/ASN.2008060590","article-title":"Effect of membrane permeability on survival of hemodialysis patients","volume":"20","author":"Locatelli","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000333816","article-title":"The membrane permeability outcome study","volume":"175","author":"Locatelli","year":"2011","journal-title":"Contrib Nephrol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"e0129575","DOI":"10.1371\/journal.pone.0129575","article-title":"Dialyzer reuse and outcomes of high flux dialysis","volume":"10","author":"Argyropoulos","year":"2015","journal-title":"PLoS One"},{"key":"B230","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000380767","article-title":"Effect of membrane permeability on cardiovascular risk factors and \u03b22m plasma levels in patients on long-term haemodialysis: a randomised crossover trial","volume":"129","author":"Chazot","year":"2015","journal-title":"Nephron"},{"key":"B231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000450632","article-title":"Haemodiafiltration at higher volumes and patient survival","volume":"189","author":"Locatelli","year":"2016","journal-title":"Contrib Nephrol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/sdi.12200","article-title":"Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis","volume":"27","author":"Mostovaya","year":"2014","journal-title":"Semin Dial"},{"key":"B233","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1053\/j.ajkd.2013.12.004","article-title":"Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials","volume":"63","author":"Nistor","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B234","doi-asserted-by":"publisher","first-page":"CD006258","DOI":"10.1002\/14651858.CD006258.pub2","article-title":"Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease","volume":"5","author":"Nistor","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B235","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1093\/ndt\/gft396","article-title":"Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials","volume":"28","author":"Susantitaphong","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B236","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1053\/j.ajkd.2014.01.435","article-title":"Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials","volume":"63","author":"Wang","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/ki.2015.139","article-title":"Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration","volume":"88","author":"Canaud","year":"2015","journal-title":"Kidney Int"},{"key":"B238","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/sj.ki.5000447","article-title":"Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS","volume":"69","author":"Canaud","year":"2006","journal-title":"Kidney Int"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1681\/ASN.2011121140","article-title":"Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes","volume":"23","author":"Grooteman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ndt\/gfs407","article-title":"Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study","volume":"28","author":"Ok","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B241","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1681\/ASN.2012080875","article-title":"High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients","volume":"24","author":"Maduell","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfv349","article-title":"Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials","volume":"31","author":"Peters","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B243","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.ajkd.2008.05.011","article-title":"The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial","volume":"52","author":"Santoro","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B244","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000439060","article-title":"Serum \u03b22-microglobulin predicts mortality in peritoneal dialysis patients: a prospective cohort study","volume":"42","author":"Koh","year":"2015","journal-title":"Am J Nephrol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000449029","article-title":"Advances in understanding and management of residual renal function in patients with chronic kidney disease","volume":"2","author":"Liu","year":"2017","journal-title":"Kidney Dis (Basel)"},{"key":"B246","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.kint.2016.02.037","article-title":"Preservation of residual kidney function in hemodialysis patients: reviving an old concept","volume":"90","author":"Mathew","year":"2016","journal-title":"Kidney Int"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0272-6386(03)00362-7","article-title":"The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2","volume":"41","author":"Termorshuizen","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B248","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2215\/CJN.05540610","article-title":"Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients","volume":"6","author":"Balafa","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B249","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1681\/ASN.2006030194","article-title":"Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis","volume":"17","author":"Brimble","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3747\/pdi.2013.00217","article-title":"Peritoneal protein clearance rather than faster transport status determines outcomes in peritoneal dialysis patients","volume":"35","author":"Rajakaruna","year":"2015","journal-title":"Perit Dial Int"},{"key":"B251","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"N Engl J Med"},{"key":"B252","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/ndt\/gft087","article-title":"Pathophysiology and treatment options of chronic renal allograft damage","volume":"28","author":"Heemann","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B253","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/ajt.13180","article-title":"Renal allograft fibrosis: biology and therapeutic targets","volume":"15","author":"Boor","year":"2015","journal-title":"Am J Transplant"},{"key":"B254","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clinbiochem.2011.10.018","article-title":"Accuracy of GFR predictive equations in renal transplantation: validation of a new turbidimetric cystatin C assay on Architect c8000","volume":"45","author":"Bargnoux","year":"2012","journal-title":"Clin Biochem"},{"key":"B255","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/TP.0b013e3182301602","article-title":"Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulas","volume":"92","author":"Buron","year":"2011","journal-title":"Transplantation"},{"key":"B256","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1600-6143.2009.02954.x","article-title":"Pathological and clinical characterization of the \u2018troubled transplant\u2019: data from the DeKAF Study","volume":"10","author":"Gourishankar","year":"2010","journal-title":"Am J Transplant"},{"key":"B257","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2215\/CJN.01681105","article-title":"Beyond histology: novel tools to diagnose allograft dysfunction","volume":"1","author":"Mannon","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14258","article-title":"Filtration markers, cardiovascular disease, mortality, and kidney outcomes in stable kidney transplant recipients: the FAVORIT trial","author":"Foster","year":"2017","journal-title":"Am J Transplant"},{"key":"B259","doi-asserted-by":"publisher","first-page":"562580","DOI":"10.1155\/2015\/562580","article-title":"High serum level of \u03b22-microglobulin in late posttransplant period predicts subsequent decline in kidney allograft function: a preliminary study","volume":"2015","author":"Trailin","year":"2015","journal-title":"Dis Markers"},{"key":"B260","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/tan.12775","article-title":"Many de novo donor-specific antibodies recognize \u03b22-microglobulin-free, but not intact HLA heterodimers","volume":"87","author":"Michel","year":"2016","journal-title":"HLA"},{"key":"B261","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/prca.201000160","article-title":"Identification of \u03b22-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods","volume":"5","author":"Johnston","year":"2011","journal-title":"Proteomics Clin Appl"},{"key":"B262","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/prca.201400200","article-title":"Urinary biomarkers of chronic allograft nephropathy","volume":"9","author":"Cassidy","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"B263","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01.ASN.0000101031.52826.BE","article-title":"Proteomic-based detection of urine proteins associated with acute renal allograft rejection","volume":"15","author":"Schaub","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B264","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1600-6143.2005.00766.x","article-title":"Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts","volume":"5","author":"Schaub","year":"2005","journal-title":"Am J Transplant"},{"key":"B265","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1053\/j.ajkd.2006.01.034","article-title":"Urinary beta2-microglobulin is associated with acute renal allograft rejection","volume":"47","author":"Oetting","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B266","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1097\/TP.0b013e3181a66595","article-title":"Urinary peptide patterns in native kidneys and kidney allografts","volume":"87","author":"Zhang","year":"2009","journal-title":"Transplantation"},{"key":"B267","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3109\/08860229809045167","article-title":"Urinary excretion of proteins and tubular enzymes in renal transplant patients","volume":"20","author":"Donadio","year":"1998","journal-title":"Ren Fail"},{"key":"B268","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10067-013-2220-8","article-title":"Serum \u03b22-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still\u2019s disease","volume":"32","author":"Wakabayashi","year":"2013","journal-title":"Clin Rheumatol"},{"key":"B269","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5045\/br.2014.49.3.148","article-title":"Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor","volume":"49","author":"Yoo","year":"2014","journal-title":"Blood Res"},{"key":"B270","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/ar3256","article-title":"Renal co-morbidity in patients with rheumatic diseases","volume":"13","author":"Anders","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B271","doi-asserted-by":"publisher","first-page":"e0136508","DOI":"10.1371\/journal.pone.0136508","article-title":"Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications \u2013 a national population-based cohort study","volume":"10","author":"Chiu","year":"2015","journal-title":"PLoS One"},{"key":"B272","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1741-7015-11-95","article-title":"Renal involvement in autoimmune connective tissue diseases","volume":"11","author":"Kronbichler","year":"2013","journal-title":"BMC Med"},{"key":"B273","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/hon.2188","article-title":"Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma","volume":"34","author":"Yoo","year":"2016","journal-title":"Hematol Oncol"},{"key":"B274","doi-asserted-by":"publisher","first-page":"76934","DOI":"10.18632\/oncotarget.12734","article-title":"Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era","volume":"7","author":"Seo","year":"2016","journal-title":"Oncotarget"},{"key":"B275","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1158\/1078-0432.CCR-07-2063","article-title":"The prognostic significance of serum \u03b22 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients","volume":"14","author":"Tsimberidou","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B276","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bjh.12409","article-title":"Prognostic impact of monocyte count at presentation in mantle cell lymphoma","volume":"162","author":"von Hohenstaufen","year":"2013","journal-title":"Br J Haematol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"72219","DOI":"10.18632\/oncotarget.12663","article-title":"Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B278","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1182\/blood.V126.23.3888.3888","article-title":"The NCCN-IPI helps to identify very high-risk patients with DLBCL and can be improved by other independent clinical factors including bulky disease and beta2-microglobulin","volume":"126","author":"Coutinho","year":"2015","journal-title":"Blood"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2312","article-title":"Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma","author":"Kanemasa","year":"2016","journal-title":"Hematol Oncol"},{"key":"B280","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/cncr.24959","article-title":"Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma","volume":"116","author":"Rossi","year":"2010","journal-title":"Cancer"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/sj.bmt.1701787","article-title":"Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma","volume":"23","author":"Rajkumar","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"B282","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.transproceed.2007.08.052","article-title":"Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma","volume":"39","author":"Stella-Holowiecka","year":"2007","journal-title":"Transplant Proc"},{"key":"B283","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"B284","doi-asserted-by":"publisher","first-page":"e0166841","DOI":"10.1371\/journal.pone.0166841","article-title":"Prognostic value of serum free light chains measurements in multiple myeloma patients","volume":"11","author":"Garc\u00eda de Veas Silva","year":"2016","journal-title":"PLoS One"},{"key":"B285","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ajh.24236","article-title":"Myeloma today: disease definitions and treatment advances","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Am J Hematol"},{"key":"B286","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/leu.2015.65","article-title":"The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma","volume":"29","author":"Papanikolaou","year":"2015","journal-title":"Leukemia"},{"key":"B287","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2007-01-067728","article-title":"High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis","volume":"110","author":"van Rhee","year":"2007","journal-title":"Blood"},{"key":"B288","first-page":"4299","article-title":"Renal Insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statement","volume":"34","author":"Park","year":"2014","journal-title":"Anticancer Res"},{"key":"B289","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11899-015-0294-x","article-title":"Prognostic factors for chronic lymphocytic leukemia","volume":"11","author":"Chen","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"key":"B290","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3324\/haematol.2009.005561","article-title":"Predictive value of \u03b22-microglobulin (\u03b22-m) levels in chronic lymphocytic leukemia since Binet A stages","volume":"94","author":"Gentile","year":"2009","journal-title":"Haematologica"},{"key":"B291","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3324\/haematol.13103","article-title":"CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia","volume":"93","author":"Rossi","year":"2008","journal-title":"Haematologica"},{"key":"B292","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/cncr.29794","article-title":"\u03b22-microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior PFS in CLL","volume":"122","author":"Thompson","year":"2016","journal-title":"Cancer"},{"key":"B293","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/prca.200900171","article-title":"Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients","volume":"4","author":"H\u00f8gdall","year":"2010","journal-title":"Proteomics Clin Appl"},{"key":"B294","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10735-014-9597-9","article-title":"ATP5b and \u03b22-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer","volume":"46","author":"Sun","year":"2015","journal-title":"J Mol Histol"},{"key":"B295","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.arcmed.2013.03.008","article-title":"Correlation of serum \u03b22-microglobulin levels with prostate-specific antigen, Gleason score, clinical stage, tumor metastasis and therapy efficacy in prostate cancer","volume":"44","author":"Zhang","year":"2013","journal-title":"Arch Med Res"},{"key":"B296","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1744-313X.1996.tb00132.x","article-title":"Correlation between tumour and serum beta 2m expression in patients with breast cancer","volume":"23","author":"Klein","year":"1996","journal-title":"Eur J Immunogenet"},{"key":"B297","doi-asserted-by":"publisher","first-page":"e689795","DOI":"10.1155\/2014\/689795","article-title":"Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma","volume":"2014","author":"Lucarelli","year":"2014","journal-title":"Dis Markers"},{"key":"B298","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/diagnostics7010014","article-title":"A perspective on ovarian cancer biomarkers: past, present and yet-to-come","volume":"7","author":"Ueland","year":"2017","journal-title":"Diagnostics (Basel)"},{"key":"B299","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","article-title":"Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors","volume":"117","author":"Ueland","year":"2011","journal-title":"Obstet Gynecol"},{"key":"B300","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/1055-9965.EPI-15-0849","article-title":"Circulating beta-2 microglobulin and risk of cancer: the atherosclerosis risk in communities study (ARIC)","volume":"25","author":"Prizment","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B301","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/0961203312447668","article-title":"Increased serum \u03b22-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients","volume":"21","author":"Hermansen","year":"2012","journal-title":"Lupus"},{"key":"B302","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1136\/ard.2008.095257","article-title":"Quantitative assessment of antibodies to ribonucleoproteins in primary Sj\u00f6gren syndrome: correlation with B-cell biomarkers and disease activity","volume":"68","author":"Candon","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B303","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/ard.2004.030643","article-title":"Correlation of serum B lymphocyte stimulator and \u00df2 microglobulin with autoantibody secretion and systemic involvement in primary Sj\u00f6gren\u2019s syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B304","doi-asserted-by":"publisher","first-page":"e59868","DOI":"10.1371\/journal.pone.0059868","article-title":"Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in Primary Sj\u00f6gren\u2019s Syndrome. Data at enrollment in the prospective ASSESS cohort","volume":"8","author":"Gottenberg","year":"2013","journal-title":"PLoS One"},{"key":"B305","doi-asserted-by":"publisher","first-page":"e1523959","DOI":"10.1155\/2016\/1523959","article-title":"The prognostic significance of beta2 microglobulin in patients with hemophagocytic lymphohistiocytosis","volume":"2016","author":"Jiang","year":"2016","journal-title":"Dis Markers"},{"key":"B306","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5414\/CN108142","article-title":"Renal tubular dysfunction in patients with primary Sj\u00f6gren syndrome","volume":"81","author":"Amarante","year":"2014","journal-title":"Clin Nephrol"},{"key":"B307","doi-asserted-by":"publisher","first-page":"e44201","DOI":"10.1371\/journal.pone.0044201","article-title":"Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease","volume":"7","author":"Neirynck","year":"2012","journal-title":"PLoS One"},{"key":"B308","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B309","doi-asserted-by":"publisher","first-page":"e0123784","DOI":"10.1371\/journal.pone.0123784","article-title":"Analysis of time to event outcomes in randomized controlled trials by generalized additive models","volume":"10","author":"Argyropoulos","year":"2015","journal-title":"PLoS One"},{"key":"B310","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbrc.2007.05.100","article-title":"The hereditary hemochromatosis protein HFE and its chaperone beta2-microglobulin localise predominantly to the endosomal-recycling compartment","volume":"359","author":"Bhatt","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B311","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.4049\/jimmunol.181.4.2572","article-title":"The MHC class II-associated invariant chain interacts with the neonatal Fc gamma receptor and modulates its trafficking to endosomal\/lysosomal compartments","volume":"181","author":"Ye","year":"2008","journal-title":"J Immunol"},{"key":"B312","doi-asserted-by":"publisher","first-page":"c113","DOI":"10.1159\/000094446","article-title":"Reduced capacity of mononuclear cells to synthesize cytokines against an inflammatory stimulus in uremic patients","volume":"104","author":"Ando","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"B313","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5414\/CNP60327","article-title":"Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure","volume":"60","author":"Lonnemann","year":"2003","journal-title":"Clin Nephrol"},{"key":"B314","first-page":"341","article-title":"Tuberculosis in California dialysis patients","volume":"8","author":"Ahmed","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"B315","first-page":"989","article-title":"Risk of tuberculosis in dialysis patients: a population-based study","volume":"2","author":"Chia","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"B316","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000045974","article-title":"Tuberculosis in maintenance dialysis patients","volume":"88","author":"Chou","year":"2001","journal-title":"Nephron"},{"key":"B317","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2215\/CJN.01290308","article-title":"Epidemiology of acute infections among patients with chronic kidney disease","volume":"3","author":"Dalrymple","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B318","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"B319","first-page":"253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel","year":"2010","journal-title":"J Nephrol"},{"key":"B320","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"B321","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1681\/ASN.2015040373","article-title":"Variation in cancer incidence among patients with ESRD during kidney function and nonfunction intervals","volume":"27","author":"Yanik","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B322","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","article-title":"Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009","volume":"65","author":"Butler","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B323","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/mco.2016.952","article-title":"Cancer risk in patients receiving renal replacement therapy: a meta-analysis of cohort studies","volume":"5","author":"Shang","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"B324","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ki.1991.212","article-title":"Stimulation of beta 2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes","volume":"40","author":"Jahn","year":"1991","journal-title":"Kidney Int"},{"key":"B325","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0272-6386(12)80267-8","article-title":"Stimulation of mononuclear cells by contact with cuprophan membranes: further increase of beta 2-microglobulin synthesis by activated late complement components","volume":"21","author":"Schoels","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"B326","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0272-6386(12)80432-X","article-title":"Synthesis of beta 2-microglobulin in lymphocyte culture: role of hemodialysis, dialysis membranes, dialysis-amyloidosis, and lymphokines","volume":"22","author":"Campistol","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"B327","first-page":"284","article-title":"Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies","volume":"3","author":"Zingraff","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"B328","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1046\/j.1523-1755.2001.07816.x","article-title":"Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?","volume":"78","author":"Haufe","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"B329","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/ki.1990.298","article-title":"Effects of dialysis membranes on beta 2-microglobulin production and cellular expression","volume":"38","author":"Zaoui","year":"1990","journal-title":"Kidney Int"},{"key":"B330","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000110069","article-title":"Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study","volume":"25","author":"Traut","year":"2007","journal-title":"Blood Purif"},{"key":"B331","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1525-139X.2009.00574.x","article-title":"The role of EUTox in uremic toxin research","volume":"22","author":"Vanholder","year":"2009","journal-title":"Semin Dial"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:28:23Z","timestamp":1692840503000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":331,"alternative-id":["10.3389\/fmed.2017.00073"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00073","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]},"article-number":"73"}}